CompletedPhase 2NCT00426842

A Dose Response Trial Using 5 and 10 Mg of Midodrine Hydrochloride

Studying Rare autonomic nervous system disorder

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
James J. Peters Veterans Affairs Medical Center
Principal Investigator
Jill Wecht, EdD
VA Medical Center, Bronx
Intervention
Midodrine Hydrochloride(drug)
Enrollment
11 enrolled
Eligibility
18-65 years · All sexes
Timeline
20072011

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00426842 on ClinicalTrials.gov

Other trials for Rare autonomic nervous system disorder

Additional recruiting or active studies for the same condition.

See all trials for Rare autonomic nervous system disorder

← Back to all trials